{"data":{"id":"us-il/305-ilcs-5-5-57","jurisdiction":"us-il","citation":"305 ILCS 5/5-57","heading":"Genetic testing and evidence-based screenings for an inherited gene mutation.","body":"(a) In this Section, \"genetic testing for an inherited mutation\" means germline multi-gene testing for an inherited mutation associated with an increased risk of cancer in accordance with evidence-based, clinical practice guidelines.\n(b) Subject to federal approval, the medical assistance program, after January 1, 2026, shall provide coverage for clinical genetic testing for an inherited gene mutation for individuals with a personal or family history of cancer, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, including, but not limited to, the current version of the National Comprehensive Cancer Network clinical practice guidelines.\n(c) For individuals with a genetic test that is positive for an inherited mutation associated with an increased risk of cancer, coverage required under this Section shall include any evidence-based screenings, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, to the extent that the management recommendation is not already covered by the medical assistance program. In this subsection, \"evidence-based cancer screenings\" means medically recommended evidence-based screening modalities in accordance with current clinical practice guidelines.","path":["CHAPTER 305 PUBLIC AID","Illinois Public Aid Code."],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=1413\u0026ChapterID=28\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:32Z","sha256":"5fd7eb5e9498dd36ce078dcf19ed9eff5c1b677530aaca97877a7ddeaae02594","source_id":"us-il","stale":false,"prev":"us-il/305-ilcs-5-5-56","next":"us-il/305-ilcs-5-5-58"},"notice":"GroundRules: Original legal text. Not legal advice."}